{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:27Z","timestamp":1787010207869,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,10]]},"abstract":"<jats:p>Abnormal transient receptor potential (TRP) channel function interferes with intracellular calcium-based signaling and causes malignant phenotypes. However, the effects of TRP channel-related genes on hepatocellular carcinoma (HCC) remain unclear. This study aimed to identify HCC molecular subtypes and prognostic signatures based on TRP channel-related genes to predict prognostic risks. Unsupervised hierarchical clustering was applied to identify HCC molecular subtypes using the expression data of TRP channel-related genes. This was followed by a comparison of the clinical and immune microenvironment characteristics between the resulting subtypes. After screening for differentially expressed genes among subtypes, prognostic signatures were identified to construct risk score-based prognostic and nomogram models and predict HCC survival. Finally, tumor drug sensitivities were predicted and compared between the risk groups. Sixteen TRP channel-related genes that were differentially expressed between HCC and non-tumorous tissues were used to identify 2 subtypes. Cluster 1 had higher TRP scores, better survival status, and lower levels of clinical malignancy. Immune-related analyses also revealed higher infiltration of M1 macrophages and higher immune and stromal scores in Cluster 1 than in Cluster 2. After screening differentially expressed genes between subtypes, 6 prognostic signatures were identified to construct prognostic and nomogram models. The potential of these models to assess the prognostic risk of HCC was further validated. Furthermore, Cluster 1 was more distributed in the low-risk group, with higher drug sensitivities. Two HCC subtypes were identified, of which Cluster 1 was associated with a favorable prognosis. Prognostic signatures related to TRP channel genes and molecular subtypes can be used to predict HCC risk.<\/jats:p>","DOI":"10.1097\/md.0000000000033228","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T12:01:10Z","timestamp":1678449670000},"page":"e33228","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Identification of molecular subtypes and prognostic signatures based on transient receptor potential channel-related genes to predict the prognostic risk of hepatocellular carcinoma: A review"],"prefix":"10.1097","volume":"102","author":[{"given":"Dongyang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Tangshan Central Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Tangshan Central Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Tangshan Central Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganggang","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Tangshan Central Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Tangshan Central Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyou","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Tangshan Central Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-9449","authenticated-orcid":false,"given":"Jianxing","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Tangshan Central Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3748\/wjg.v25.i13.1550","article-title":"Hepatocellular carcinoma surveillance: an evidence-based approach.","volume":"25","author":"Harris","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"104313104313","DOI":"10.1016\/j.ejmg.2021.104313","article-title":"Rare variants of primary liver cancer: fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas.","volume":"64","author":"Wege","year":"2021","journal-title":"Eur J Med Genet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma.","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2020.08.014","article-title":"Advances in hepatocellular carcinoma.","volume":"24","author":"Frenette","year":"2020","journal-title":"Clin Liver Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/15733998113099990068","article-title":"The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives.","volume":"9","author":"Facciorusso","year":"2013","journal-title":"Curr Diabetes Rev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/cancers12040874","article-title":"Statin use decreases the incidence of hepatocellular carcinoma: an updated meta-analysis.","volume":"12","author":"Facciorusso","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5582\/bst.2021.01094","article-title":"Surgical treatment of hepatocellular carcinoma.","volume":"15","author":"Sugawara","year":"2021","journal-title":"Biosci Trends"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1007\/s00261-021-03065-0","article-title":"Frontiers of therapy for hepatocellular carcinoma.","volume":"46","author":"Heller","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/cancers12010036","article-title":"Efficacy of regorafenib in hepatocellular carcinoma patients: a systematic review and meta-analysis.","volume":"12","author":"Facciorusso","year":"2019","journal-title":"Cancers"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/liv.14735","article-title":"The changing scenario of hepatocellular carcinoma in Italy: an update.","volume":"41","author":"Garuti","year":"2021","journal-title":"Liver Int"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification.","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv Cancer Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-021-00245-6","article-title":"Hepatocellular carcinoma.","volume":"7","author":"Maennich","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-981-10-7757-9_6","article-title":"Transient receptor potential (TRP) channels.","volume":"87","author":"Samanta","year":"2018","journal-title":"Subcell Biochem"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/ijms21051739","article-title":"Transient receptor potential canonical (TRPC) channels as modulators of migration and invasion.","volume":"21","author":"Asghar","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12272-021-01319-5","article-title":"Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials.","volume":"44","author":"Gao","year":"2021","journal-title":"Arch Pharm Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5483\/BMBRep.2020.53.3.016","article-title":"Emerging role of transient receptor potential (TRP) channels in cancer progression.","volume":"53","author":"Yang","year":"2020","journal-title":"BMB Rep"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"8892312","DOI":"10.1155\/2020\/8892312","article-title":"TRPV2: A cancer biomarker and potential therapeutic target.","volume":"2020","author":"Siveen","year":"2020","journal-title":"Dis Markers"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.biopha.2018.06.029","article-title":"Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.","volume":"105","author":"Hu","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cancergencyto.2009.08.007","article-title":"Clinical significance of transient receptor potential vanilloid 2 expression in human hepatocellular carcinoma.","volume":"197","author":"Liu","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"8114327","DOI":"10.1155\/2021\/8114327","article-title":"Involvement of TRPC7-AS1 expression in hepatitis B virus-related hepatocellular carcinoma.","volume":"2021","author":"Zhu","year":"2021","journal-title":"J Oncol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-021-01904-y","article-title":"Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.","volume":"40","author":"Wang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"8757656","DOI":"10.1155\/2022\/8757656","article-title":"A TRP family based signature for prognosis prediction in head and neck squamous cell carcinoma.","volume":"2022","author":"Pan","year":"2022","journal-title":"J Oncol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/bioinformatics\/bty920","article-title":"gwasurvivr: an R package for genome-wide survival analysis.","volume":"35","author":"Rizvi","year":"2019","journal-title":"Bioinformatics"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT.","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2506843","DOI":"10.1155\/2019\/2506843","article-title":"Deciphering immune-associated genes to predict survival in clear cell renal cell cancer.","volume":"2019","author":"Hu","year":"2019","journal-title":"Biomed Res Int"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.7150\/jca.35785","article-title":"A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms.","volume":"10","author":"Zhang","year":"2019","journal-title":"J Cancer"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels.","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.21105\/joss.02017","article-title":"ggalluvial: layered grammar for alluvial plots.","volume":"5","author":"Brunson","year":"2020","journal-title":"J Open Source Softw"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1002\/jcb.27259","article-title":"IL-6\/STAT3 pathway intermediates M1\/M2 macrophage polarization during the development of hepatocellular carcinoma.","volume":"119","author":"Yin","year":"2018","journal-title":"J Cell Biochem"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/jcb.26509","article-title":"Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1\/M2 macrophage polarization.","volume":"119","author":"Ye","year":"2018","journal-title":"J Cell Biochem"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"6347592","DOI":"10.1155\/2021\/4614257","article-title":"Macrophages M1-related prognostic signature in hepatocellular carcinoma.","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Oncol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"107938","DOI":"10.1016\/j.intimp.2021.107938","article-title":"The Notch signaling pathway regulates macrophage polarization in liver diseases.","volume":"99","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"803037","DOI":"10.3389\/fimmu.2021.803037","article-title":"Macrophage polarization and its role in liver disease.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000503452","article-title":"Inhibition of canonical transient receptor potential 5 channels polarizes macrophages to an M1 phenotype.","volume":"105","author":"Tao","year":"2020","journal-title":"Pharmacology"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.12659\/MSM.916202","article-title":"Formiminotransferase cyclodeaminase suppresses hepatocellular carcinoma by modulating cell apoptosis, DNA damage, and phosphatidylinositol 3-kinases (PI3K)\/Akt signaling pathway.","volume":"25","author":"Chen","year":"2019","journal-title":"Med Sci Monit"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12029-019-00211-2","article-title":"The diagnostic value of Arginase-1, FTCD, and MOC-31 expression in early detection of hepatocellular carcinoma (HCC) and in differentiation between HCC and metastatic adenocarcinoma to the liver.","volume":"51","author":"Labib","year":"2020","journal-title":"J Gastrointest Cancer"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/ijms22031474","article-title":"Analysis of m6A RNA methylation-related genes in liver hepatocellular carcinoma and their correlation with survival.","volume":"22","author":"Li","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R40-20250504","first-page":"6924","article-title":"SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by miR-181c.","volume":"11","author":"Wang","year":"2019","journal-title":"Am J Transl Res"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00262-021-02967-8","article-title":"Construction of TME and identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.","volume":"71","author":"Liu","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"13639","DOI":"10.1038\/s41598-022-17954-x","article-title":"Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model.","volume":"12","author":"Dai","year":"2022","journal-title":"Sci Rep"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10753-017-0724-0","article-title":"Transient receptor potential Ankyrin 1 (TRPA1) mediates lipopolysaccharide (LPS)-induced inflammatory responses in primary human osteoarthritic fibroblast-like synoviocytes.","volume":"41","author":"Yin","year":"2018","journal-title":"Inflammation"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/sj.jid.5700880","article-title":"Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes.","volume":"127","author":"Li","year":"2007","journal-title":"J Invest Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T22:47:00Z","timestamp":1746312420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033228","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,10]]}}}